Regulation of matrix metalloproteinase-19 messenger RNA expression in the rat ovary

Biol Reprod. 2004 Dec;71(6):1796-806. doi: 10.1095/biolreprod.104.031823. Epub 2004 Jul 30.

Abstract

Matrix metalloproteinases (MMPs) are instrumental in the constant tissue remodeling in the ovary. An induction of MMP-19 mRNA in periovulatory follicles has been reported in mouse ovaries. However, little is known about MMP-19 expression during the follicular and luteal periods or about the ovarian regulation of MMP-19 mRNA expression. We examined the expression pattern of MMP-19 mRNA during various reproductive phases and the periovulatory regulation of MMP-19 mRNA in the rat ovary. In gonadotropin-primed, immature rat ovaries, levels of MMP-19 mRNA transiently increased during both follicular growth and ovulation. The MMP-19 mRNA was localized to the theca-interstitial layer of growing follicles and to the granulosa and theca-interstitial layers of periovulatory follicles. A similar expression pattern of MMP-19 mRNA in periovulatory follicles was observed in ovaries from naturally cycling adult rats. Accumulation of MMP-19 mRNA was detected in regressing corpus luteum. The regulation of MMP-19 mRNA expression during the periovulatory period was investigated via in vivo studies and through in vitro culture studies on follicular cells. The hCG-induction of MMP-19 mRNA was mimicked by treating granulosa cells, but not theca-interstitial cells, from preovulatory follicles with LH or activators of the protein kinase (PK) A or PKC pathways. Cycloheximide blocked the LH- or forskolin-induced MMP-19 mRNA expression, demonstrating the requirement for new protein synthesis. In contrast, blocking activation of the progesterone receptor or prostaglandin synthesis had no effect on the increase in MMP-19 mRNA expression. In conclusion, the induction of MMP-19 mRNA suggests an important role of this proteinase during follicular growth, ovulation, and luteal regression.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cells, Cultured
  • Cycloheximide / pharmacology
  • Cyclooxygenase Inhibitors / pharmacology
  • Female
  • Follicular Phase
  • Gene Expression Regulation*
  • Gonanes / pharmacology
  • Granulosa Cells / enzymology
  • Hormone Antagonists / pharmacology
  • Indomethacin / pharmacology
  • Luteal Phase
  • Luteinizing Hormone / pharmacology
  • Matrix Metalloproteinases, Secreted
  • Metalloendopeptidases / genetics*
  • Mifepristone / pharmacology
  • Ovary / enzymology*
  • Ovulation
  • Protein Synthesis Inhibitors / pharmacology
  • RNA, Messenger / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction
  • Theca Cells / enzymology
  • Tissue Distribution

Substances

  • Cyclooxygenase Inhibitors
  • Gonanes
  • Hormone Antagonists
  • Protein Synthesis Inhibitors
  • RNA, Messenger
  • Mifepristone
  • Luteinizing Hormone
  • Cycloheximide
  • Matrix Metalloproteinases, Secreted
  • Metalloendopeptidases
  • matrix metalloproteinase 19
  • onapristone
  • Indomethacin